Cell Therapy is Associated with Reduction of Functional Mitral Regurgitation in Cardiomyopathy Patients with High End-Diastolic Volumes
In nonischemic cardiomyopathy (NICM), CD34+ cell transplantation was shown to improve left ventricular dimensions and function. We sought to investigate the effects of such therapy on functional mitral regurgitation (FMR) in this patient cohort.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: S. Frljak, G. Zemljic, G. Poglajen, A. Cerar, M. Jaklic, F. Haddad, B. Vrtovec Tags: 328 Source Type: research
More News: Cardiology | Cardiomyopathy | Heart | Heart Transplant | Lung Transplant | Transplant Surgery | Transplants